title: Role of cetuximab in the treatment of patients with NSCLC: are we throwing out the baby with the bath water?
authors.forename: Irene
authors.initials: I
authors.lastname: Floriani
authors.forename: Marina Chiara
authors.initials: MC
authors.lastname: Garassino
authors.forename: Massimo
authors.initials: M
authors.lastname: Broggini
authors.forename: Silvio
authors.initials: S
authors.lastname: Veronese
authors.forename: Silvia
authors.initials: S
authors.lastname: Marsoni
authors.forename: Mirko
authors.initials: M
authors.lastname: Marabese
authors.forename: Gabriella
authors.initials: G
authors.lastname: Farina
authors.forename: Alberto
authors.initials: A
authors.lastname: Scanni
mesh_terms: D000911:Antibodies, Monoclonal / Q000008:administration & dosage; D061067:Antibodies, Monoclonal, Humanized; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D014408:Biomarkers, Tumor / Q000235:genetics; D002289:Carcinoma, Non-Small-Cell Lung / Q000188:drug therapy* / Q000235:genetics / Q000401:mortality / Q000556:secondary; D000068818:Cetuximab; D019317:Evidence-Based Medicine; D005819:Genetic Markers; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy* / Q000235:genetics / Q000401:mortality / Q000473:pathology; D018579:Patient Selection; D011237:Predictive Value of Tests; D016896:Treatment Outcome
chemical_list: D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D014408:Biomarkers, Tumor; D005819:Genetic Markers; D000068818:Cetuximab